Trupanion (TRUP) & Its Rivals Financial Review

Trupanion (NASDAQ:TRUP – Get Free Report) is one of 311 public companies in the “Insurance” industry, but how does it contrast to its rivals? We will compare Trupanion to similar businesses based on the strength of its earnings, analyst recommendations, valuation, risk, dividends, profitability and institutional ownership.

Valuation & Earnings

This table compares Trupanion and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Trupanion $1.44 billion $19.43 million 58.80
Trupanion Competitors $15.14 billion $1.70 billion 33.84

Trupanion’s rivals have higher revenue and earnings than Trupanion. Trupanion is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Trupanion and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Trupanion 1.71% 6.71% 2.89%
Trupanion Competitors 9.52% -10.06% 4.10%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Trupanion and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trupanion 0 5 1 0 2.17
Trupanion Competitors 3360 15745 16598 752 2.40

Trupanion presently has a consensus target price of $40.00, suggesting a potential upside of 11.51%. As a group, “Insurance” companies have a potential upside of 6.81%. Given Trupanion’s higher probable upside, analysts plainly believe Trupanion is more favorable than its rivals.

Institutional & Insider Ownership

55.9% of shares of all “Insurance” companies are held by institutional investors. 5.6% of Trupanion shares are held by company insiders. Comparatively, 13.4% of shares of all “Insurance” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Risk & Volatility

Trupanion has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Trupanion’s rivals have a beta of -1.59, suggesting that their average stock price is 259% less volatile than the S&P 500.

Summary

Trupanion rivals beat Trupanion on 9 of the 13 factors compared.

About Trupanion

(Get Free Report)

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.